Spelling suggestions: "subject:"amolecular targets"" "subject:"7molecular targets""
1 |
MOLECULAR RECOGNITION OF C-MYC PROMOTER G-QUADRUPLEX BY NUCLEOLIN PROTEINLuying Chen (16807251) 09 August 2023 (has links)
<p>c-Myc is one of the most important oncogenes. G-quadruplex DNA secondary structure formed in the proximal promoter region of c-Myc functions as a transcription silencer and is targetable by small molecules. Therefore, the c-Myc promoter G-quadruplex (MycG4) is an attractive anticancer drug target. Protein recognition of MycG4 is essential for its transcriptional regulating. Nucleolin was discovered as a major MycG4 binding protein in 2009. It shows a remarkably higher binding affinity for MycG4 over its known substrate NRE_RNA and overexpression of nucleolin represses the activity of the c-Myc promoter. However, little is known about its molecular recognition of MycG4. Here, we use X-ray crystallography combined with other biochemical and biophysical methods to understand how nucleolin recognizes MycG4. Nucleolin is a 77 kD protein with a modular organization. The four RNA-binding domains (RBD) of nucleolin are the minimal domains for high affinity binding with MycG4. We show that nucleolin prefers the c-Myc parallel G-quadruplex with a 6-nt central loop (Myc161) that is the thermodynamically favored conformation. Using a custom G4 DNA microarray, we optimized the MycG4 sequence with over 10-fold increased binding affinity to nucleolin. Fabs are widely used tools to facilitate crystallization and we have discovered Fabs that specifically bind the nucleolin-MycG4 complex using a phage display screening. This approach enabled us to obtain crystals of the nucleolin-MycG4-Fab ternary complex diffracted at 2.6 Å and we determined the crystal structure. In the structure, the parallel MycG4 is very well-defined with two K<sup>+</sup> between the three G-treads. The central 6-nt loop residue protrude from the G4-core and extensively recognized by the nucleolin. Only RBD1 and RBD2 of nucleolin are seen in the crystal structures and interact extensively with the 6-nt central loop and 5′-flanking of MycG4. The binding surface and area of the globular MycG4 by nucleolin is much more extensive than NRE_RNA and involves an extra binding site. Fab binds to both RBD1 and 3′-end of MycG4 to stabilize the complex. The well-defined partial RBD2-3 linker and a cavity close to the 1-nt T19 loop suggest that the missing RBD3 likely binds the 3<sup>rd</sup> loop of MycG4. This structure is the first MycG4-protein complex structure. It will help understand MycG4 and nucleolin interactions and the development of MycG4 targeted cancer therapeutics. This structure also provides novel insights into how proteins recognize the globular G-quadruplexes, highlighting the potential of G-quadruplexes as a platform for multivalent interactions such as with multiple tandem RBDs.</p>
|
2 |
DEVELOPMENT OF A LIPOPOLYSACCHARIDE ANTAGONIST FOR THE TREATMENT OF SEPSISSimseok Yuk (9173015) 10 September 2022 (has links)
<p>Sepsis and septic shock are life-threating conditions, which
resulted from a continuum of the body’s response to overwhelming infection.
Elimination of bacteria through antibiotics is not sufficient, because the host
is still left with a large amount of lipopolysaccharide (LPS) that prevents the
host immune system from returning to normal homeostasis. Synthetic LPS antagonists that
can bind to LPS via electrostatic and/or hydrophobic interactions cause systemic toxicities. Moreover, LPS elimination alone may not address already
established complications of sepsis. To address these
challenges, we propose to develop nanoparticle formulations of LPS antagonists (D-TZP)
that can be delivered systemically. Specifically, cholecalciferol (vitamin D) was encapsulated in a self-assembly of
tannic acid/Fe<sup>3+</sup> coordination complex (pTA) capsule, forming a core
that could be surface-modified with LPS
adsorbents, such as low molecular weight succinylated chitosan (LMZWC) and polymyxin B (PMB). D-TZP suppressed pro-inflammatory effects of LPS on the
engineered human monocytes with significantly less cytotoxicity than free PMB
at the equivalent dose. D-TZP increased the maximum tolerated dose of PMB by
both intraperitoneal and intravenous administration. In the LPS-induced mouse model
of sepsis, systemic administration of D-TZP immediately after LPS challenge
neutralized the lethal effect of LPS. D-TZP also reduced the mortality of mice when given 2 h after the LPS challenge.
D-TZP inhibited the mortality in the cecal
ligation and puncture (CLP)-induced bacteremia mouse model when given IV 2 h after the insult. In
the CLP model, the D-TZP-treated animals also showed lower levels of both TNF-α
and IL-10 cytokines as well as D-dimer levels, reflecting the attenuation of disseminated
intravascular coagulation, compared to the vehicle-treated control group.
Collectively, these results support that the D-TZP is a safe and effective
systemic intervention of sepsis.<br></p>
|
3 |
MicroRNoma dos carcinomas de fígadoAriede, Jovita Ramos. January 2017 (has links)
Orientador: Patricia Pintor dos Reis / Resumo: Introdução: O carcinoma hepatocelular (CHC) está entre as neoplasias de alta complexidade no diagnóstico, determinação do prognóstico e tratamento, sendo o sexto tipo de câncer mais comum no mundo e a segunda causa mais comum de morte por câncer. Uma variedade de genes alterados foram relatados, revelando heterogeneidade genética entre tumores de diferentes pacientes. Portanto, o insucesso terapêutico da terapia convencional pode ser parcialmente atribuído a essa heterogeneidade associada ao comportamento biológico tumoral. Sendo assim, justifica-se a necessidade de identificação de vias moleculares as quais podem conter biomarcadores clinicamente aplicáveis para a melhoria do diagnóstico e tratamento dos pacientes com CHC. Os resultados podem ter futuras aplicações clínicas utilizando miRNAs e os genes-alvo regulados por miRNAs como biomarcadores com valor diagnóstico, prognóstico e terapêutico. Objetivos: Identificar o perfil global de expressão de miRNAs (microRNoma) e os mRNAs-alvo potencialmente regulados por miRNAs em CHC. Pacientes e Métodos: Foram incluídas 18 amostras de tecido, fixadas em formalina e emblocadas em parafina (FFPE) de carcinoma hepatocelular, sendo 18 amostras tumorais e 18 amostras de tecido hepático histologicamente normal, adjacente ao tumor, dos mesmos pacientes. O perfil de expressão de miRNAs das amostras tumorais foi determinado utilizando o ensaio TaqMan Array Human MicroRAN Cards (TLDA) (card A) (Life Technologies). A análise dos dados util... (Resumo completo, clicar acesso eletrônico abaixo) / Doutor
|
4 |
Mecanismo da ação antineoplasica de substancias bioativas e alvos moleculares estrategicos para a indução de morte de celulas tumorais / Antineoplastic action mechanism of bioactive compounds and strategical molecular targets for inducting tumoral cells deathSouza, Ana Carolina Santos de 08 August 2018 (has links)
Orientadores: Carmen Verissima Ferreira, Hiroshi Aoyama / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-08T07:42:49Z (GMT). No. of bitstreams: 1
Souza_AnaCarolinaSantosde_D.pdf: 3901394 bytes, checksum: ef9ac69de23f7f2b15590ee29a931c8f (MD5)
Previous issue date: 2007 / Resumo: Produtos naturais têm originado muitos dos compostos biologicamente ativos usados clinicamente, destacando-se como importantes fontes de novos agentes terapêuticos utilizados no tratamento das mais variadas patologias incluindo câncer, HIV/AIDS, Alzheimer e malária. O desenvolvimento de novos fármacos a partir de produtos naturais, especialmente os derivados de plantas, tem desempenhado importante papel na prevenção e tratamento do câncer sendo que, de todos os antitumorais disponíveis entre 1940 e 2002, aproximadamente 40% eram caracterizados como produtos naturais ou derivados destes, com outros 8% sendo considerados agentes mimetizantes de produtos naturais. No presente trabalho, fisetin (flavonóide de origem vegetal) e a vitamina riboflavina foram
avaliados como potenciais agentes antitumorais. Para este propósito, as linhagens de células leucêmicas HL60 e de câncer prostático PC3 foram tratadas com riboflavina irradiada ou fisetin por 24 horas e seus efeitos sobre vias de transdução de sinais responsáveis pela sobrevivência e morte celular foram avaliados. Os resultados obtidos demonstram que riboflavina e fisetin apresentam expressiva
atividade antiproliferativa, induzindo a morte das células tumorais em concentrações na ordem de µM. A investigação do mecanismo molecular da ação citotóxica da riboflavina demonstrou que o tratamento de HL60 e PC3 com a vitamina irradiada induz morte celular através da via extrínseca de indução de apoptose, mediada pela ativação do sistema Fas/FasL e aumento na síntese de ceramida. Como conseqüência da ativação do receptor de morte Fas, uma seqüência ordenada de eventos leva à modulação de cascatas de sinalização através da alteração da atividade/expressão de moléculas-chave associadas a proliferação, sobrevivência, migração e morte celular. Assim como a riboflavina, fisetin também mostra-se eficiente indutor de morte por apoptose em células HL60, modulando cascatas de proteínas quinases e fosfatases e levando a alterações na expressão de NF?B, atividade de MAPKs, níveis de fosfoproteínas e, também, à inibição de enzimas envolvidas na manutenção do estado redox. Os resultados obtidos neste trabalho contribuem para um maior conhecimento sobre a atividade/função biológica de algumas moléculas envolvidas na sobrevivência e morte de células leucêmicas e prostáticas, sugerindo potenciais alvos para o desenvolvimento de estratégias terapêuticas mais eficazes no combate a doenças neoplásicas. Além disso, os resultados obtidos demonstram que a riboflavina irradiada e fisetin são potentes indutores de apoptose e promissores agentes antitumorais, capazes de modular importantes vias de sinalização intracelular através de ação específica sobre moléculas-chaves relacionadas a proliferação, resistência e invasividade de células tumorais / Abstract: Natural products have been providing numerous clinically used medicines and remain as essential components in the search for new drugs against various pharmacological targets including cancer, HIV/AIDS, Alzheimer¿s, malaria, and pain. Drug discovery from natural products, especially from medicinal plants, has played an important role in the chemoprevention and treatment of cancer and, off all available anticancer drugs between 1940 and 2002, about 40% were natural products per se or natural product-derived, with another 8% considered natural product mimics. In the present work, the plant flavonoid fisetin and the vitamin riboflavin are evaluated as potential anticancer agents. For this purpose, the leukemic cell line HL60 and the human prostate cancer
cell PC3 were treated for 24h with irradiated riboflavin or fisetin and their effects on signal transduction pathways related to the cell survival and proliferation were evaluated. The results obtained demonstrated that riboflavin and fisetin have strong anti-proliferative activity, inducing tumoral cell death at µM concentrations. The investigation of the molecular death mechanism triggered by riboflavin demonstrated that the treatment of HL60 and PC3 with the irradiated vitamin induces apoptotic cell death through induction of the extrinsic pathway mediated by the activation of Fas/FasL system via a ceramide-dependent pathway. As a consequence of the activation of the death receptor Fas, an orderly sequence of signaling events leads to the modulation of signaling cascades through alterations in the activity/expression of key targets molecules related to proliferation, survival, migration and cell death. As well as riboflavin, fisetin also showed strong apoptotic activity, inducing HL60 cell death through modulation of protein kinase and
phosphatase signaling cascades, leading to alterations in the NF?B expression, MAPKs activities, phosphoprotein levels and also inhibition of enzymes involved in the redox status maintenance. The results obtained in this work bring out information about the biologic activity of some molecules involved in the survival and death of leukemic and prostate cancer cells, indicating among
then potential targets for the development of rational therapeutic strategies. Moreover, the data obtained demonstrated that irradiated riboflavin and fisetin have potential proapoptotic activity, pointing out these bioactive compounds as promising antitumoral agents, since they can affect important molecular targets related to proliferation, resistance and invasibility of cancer cells / Doutorado / Bioquimica / Doutor em Biologia Funcional e Molecular
|
5 |
Characterization of a synthetic leoligin derivative, with agonistic FXR and enhancing macrophage cholesterol efflux activityKovářová, Lenka January 2016 (has links)
Charles University, Faculty of Pharmacy in Hradec Králové, Department of Biological and Medical Sciences University of Vienna, Faculty of Life Sciences, Department of Pharmacognosy Candidate: Lenka Kovářová Supervisor: Pharmdr. Miroslav Kovařík, Ph.D. Consultant: Dr. Angela Ladurner Title of the diploma thesis: Characterization of a synthetic leoligin derivative, with agonistic FXR and enhancing macrophage cholesterol efflux activity Atherosclerosis is a pathologic multifactorial process triggering the development of cardiovascular diseases, which are the leading causes of death in the western world. The initial phase of atherosclerosis is characterized by the accumulation of lipid particles, mainly low-density lipoproteins (LDL) and macrophage-derived foam cells in large arteries, leading to the gradual thickening of the vessel wall. These progressive alterations elicit plaque formation, followed by rupture, thrombosis and finally can lead to a cardiovascular event. Reverse cholesterol transport is an important preventive mechanism, which ensures removal of excessive atherogenic lipoproteins from macrophages. This efflux is facilitated by ATP binding cassette transporters, mainly ABCA1 and ABCG1 and in part by scavenger receptor B1 (SR-B1). Several nuclear receptors, including PPARγ, LXRα and LXRβ...
|
6 |
Recherche de nouvelles cibles moléculaires dans les syndromes myélodysplasiques et leucémies aiguës myéloïdes / Identification of new molecular targets in myelodysplastic syndromes and acute myeloid leukemiasRocquain, Julien 29 November 2010 (has links)
Au sein des hémopathies myéloïdes malignes, les syndromes myélodysplasiques(SMD) et les leucémies aiguës myéloïdes (LAM) représentent des pathologies complexes ethétérogènes résultant d’anomalies clonales des cellules souches médullaires. Elles sontcaractérisées par une hématopoïèse inefficace provoquant des cytopénies sanguines graves.Les connaissances sur les anomalies moléculaires des SMD et des LAM, notammentà caryotype normal, sont globalement pauvres et leur physiopathologie encore mal connue.Une meilleure définition moléculaire est nécessaire pour une évaluation pronostique plusprécise de ces hémopathies et pour optimiser secondairement les stratégies thérapeutiques.Cette thèse présente un panorama des classifications cytogénétiques et moléculairesactuelles des SMD et LAM ainsi que l’étude de certaines altérations moléculairesrencontrées dans ces maladies.Grâce à l’apport des techniques d’analyse génomique à grande échelle, notamment laCGH-array, notre laboratoire a identifié de nouvelles altérations génétiques, parmi lesquellesles mutations du gène ASXL1, ainsi que des altérations des gènes codant les protéines de laCohésine et des régulateurs de la protéine CBL. Nous avons analysé une combinaison demutations de gène et émis l’hypothèse d’un modèle de leucémogenèse à 4 classes demutations, afin d’apporter des pistes dans la compréhension de la physiopathologie des SMDet LAM. / Among myeloid malignancies, myelodysplastic syndromes (MDSs) represent a groupof complex diseases characterized by clonal abnormalities of bone marrow hematopoieticprecursor cells. They are defined by an ineffective hematopoiesis leading to peripheralcytopenias. About 40% of MDSs secondarily evolve to acute myeloid leukemia (AML).This risk of transformation is evaluated by several international prognostic scoringsystems like IPSS and WPSS. The WHO classification recognizes several classes of MDSsessentially based on morphology and cytogenetics features, some with a high progressionrisk, like refractory anemia with excess of blasts type 2, others with a low risk, likerefractory anemia with ringed sideroblasts. However, the classification of MDSs is stillunsatisfactory and relevant prognostic markers allowing earlier treatments for patients with ahigh risk of transformation are still lacking. The physiopathology of SMDs and AMLs withnormal karyotype remains unclear. Currently, the only potentially curative treatment isallogenic stem cell transplant, which is feasible for a restricted number of patients and candisplay side effects and failures.A better knowledge of the molecular biology of MDSs and AMLs is necessary for abetter understanding of these diseases and may provide new early prognosis indicators andbetter strategies of treatments.
|
7 |
Expressão gênica diferencial de lesões pré-neoplásicas hepáticas de ratos Wistar tratados com o quimiopreventivo β-ionona (βI): receptores nucleares como alvos moleculares do composto bioativo de alimentos / Differential gene expression of hepatic pre-neoplastic lesions of rats treated with the chemopreventive β-ionone (I): nuclear receptors as molecular targets of bioactive compound foodsCardozo, Mônica Testoni 04 November 2011 (has links)
A β-ionona (BI) é um isoprenóide que apresenta atividade quimiopreventiva durante a fase de promoção da hepatocarcinogênese. O presente trabalho teve como objetivo avaliar a expressão de genes modulados pela BI envolvidos na quimioprevenção durante a fase de promoção da hepatocarcinogênese induzida pelo modelo do \"Hepatócito Resistente\" (RH). Ratos Wistar machos foram submetidos ao modelo do RH e tratados durante 4 semanas consecutivas com BI (16 mg/100 g de p.c.) ou óleo de milho (OM) (0,25 ml/100 g de p.c.; grupo controle). O perfil da expressão de 1.176 genes foi analisado por macroarray no fígado dos grupos BI, OM e de ratos considerados normais (grupo N). A expressão gênica foi considerada aumentada, quando a razão de expressão foi ≥ 1,5 ou diminuída, quando ≤ 0,5. Aplicou-se análise hierárquica de clustering e classificação ontológica dos genes diferencialmente expressos. A expressão gênica foi validada por RT-PCR do tipo \"duplex\", utilizando-se tecido hepático microdissecado de: lesões pré-neoplásicas persistentes (pLPN) ou em remodelação (rLPN) e de regiões ao redor das LPN (surrounding). Um total de 133 e 32 genes foi considerado diferencialmente expresso entre os grupos OM (em relação ao N) e BI (em relação ao OM), respectivamente. Trinta e sete por cento dos genes diferencialmente expressos no grupo BI vs OM referiam-se a receptores celulares. Destes, 4 genes codificantes para receptores nucleares foram identificados como possíveis alvos da BI na quimioprevenção da hepatocarcinogênese: RXRα (receptor X de retinóide α), RARβ (receptor de ácido retinóico β), COUP-TFI (chicken ovalbumin upstream promoter-transcription factor I) e Nur77 (nuclear receptor 77). Em comparação ao grupo OM, a expressão de RXRα e RARβ foi maior (p<0,05) especificamente em pLPN e rLPN do grupo βI, respectivamente. Em comparação ao grupo N, Nur77 apresentou maior (p<0,05) expressão no surrounding e nas rLPN do grupo OM. Por outro lado, a expressão de Nur77 em rLPN foi menor (p<0,05) no grupo BI do que no OM. Comparada ao grupo N, a expressão de COUP-TFI foi maior (p<0,05) no grupo OM, tanto no surrounding das LPN como nas pLPN e rLPN. Em comparação ao grupo OM, a expressão de COUP-TFI foi menor (p<0,05) no grupo BI, especificamente nas pLPN e nas rLPN. Os resultados sugerem que os receptores nucleares RXRα, RARβ, Nur77 e COUP-TFI representam alvos moleculares da BI relevantes para a quimioprevenção da hepatocarcinogênese em ratos. / β-ionone (BI) is an isoprenoid which has chemopreventive activity during the promotion phase of hepatocarcinogenesis. This study aimed to evaluate the expression of genes modulated by BI involved in chemoprevention during the promotion phase of hepatocarcinogenesis induced model of \"Resistant Hepatocyte (RH). Male Wistar rats were submitted to the RH model and treated for 4 consecutive weeks with BI (16 mg/100 g bw) or corn oil (CO) (0.25 ml/100 g bw, control group). The expression profile of 1,176 genes was analyzed by macroarray in the liver of groups BI, CO and normal rats (group N). Gene expression was considered increased when the expression ratio was 1.5 or decreased when 0.5. Hierarchical clustering analysis and ontological classification of differentially expressed genes were applied. Gene expression was validated by RT-PCR \"duplex\", using microdissected hepatic tissue from: persistent pre-neoplastic lesions (pPNL) or remodeling pre-neoplastic lesions (rPNL) and regions around the PNL (surrounding). A total of 133 genes and 32 were considered differentially expressed between the two groups (CO to N) and BI (relative to CO), respectively. 37% of differentially expressed genes in group BI vs CO were related to cell receptors. Of these, four genes encoding for nuclear receptors have been identified as possible targets of BI in the chemoprevention of hepatocarcinogenesis: RXR (retinoid X receptor α), RARβ (retinoic acid receptor β), COUP-TFI (chicken ovalbumin upstream promoter-transcription factor I) and Nur77 (nuclear receptor 77). Compared to CO group, the expression of RXRα and RARβ was higher (p <0.05) specifically in pPNL and rPNL of BI group, respectively. Compared to the group N, Nur77 showed higher (p <0.05) expression in the surrounding and rPNL of CO group. The expression of Nur77 in rPNL was lower (p <0.05) in BI than the CO group. Compared to N group, the expression of COUP-TFI was higher (p <0.05) in CO group (surrounding, pPNL and rPNL). Compared to CO group, the expression of COUP-TFI was lower (p <0.05) in BI group, specifically in the pPNL and rPNL. The results suggest that the nuclear receptors RXRα, RARβ, Nur77 and COUP-TFI represent relevant molecular targets of BI in the chemoprevention of hepatocarcinogenesis in rats.
|
8 |
Expressão gênica diferencial de lesões pré-neoplásicas hepáticas de ratos Wistar tratados com o quimiopreventivo β-ionona (βI): receptores nucleares como alvos moleculares do composto bioativo de alimentos / Differential gene expression of hepatic pre-neoplastic lesions of rats treated with the chemopreventive β-ionone (I): nuclear receptors as molecular targets of bioactive compound foodsMônica Testoni Cardozo 04 November 2011 (has links)
A β-ionona (BI) é um isoprenóide que apresenta atividade quimiopreventiva durante a fase de promoção da hepatocarcinogênese. O presente trabalho teve como objetivo avaliar a expressão de genes modulados pela BI envolvidos na quimioprevenção durante a fase de promoção da hepatocarcinogênese induzida pelo modelo do \"Hepatócito Resistente\" (RH). Ratos Wistar machos foram submetidos ao modelo do RH e tratados durante 4 semanas consecutivas com BI (16 mg/100 g de p.c.) ou óleo de milho (OM) (0,25 ml/100 g de p.c.; grupo controle). O perfil da expressão de 1.176 genes foi analisado por macroarray no fígado dos grupos BI, OM e de ratos considerados normais (grupo N). A expressão gênica foi considerada aumentada, quando a razão de expressão foi ≥ 1,5 ou diminuída, quando ≤ 0,5. Aplicou-se análise hierárquica de clustering e classificação ontológica dos genes diferencialmente expressos. A expressão gênica foi validada por RT-PCR do tipo \"duplex\", utilizando-se tecido hepático microdissecado de: lesões pré-neoplásicas persistentes (pLPN) ou em remodelação (rLPN) e de regiões ao redor das LPN (surrounding). Um total de 133 e 32 genes foi considerado diferencialmente expresso entre os grupos OM (em relação ao N) e BI (em relação ao OM), respectivamente. Trinta e sete por cento dos genes diferencialmente expressos no grupo BI vs OM referiam-se a receptores celulares. Destes, 4 genes codificantes para receptores nucleares foram identificados como possíveis alvos da BI na quimioprevenção da hepatocarcinogênese: RXRα (receptor X de retinóide α), RARβ (receptor de ácido retinóico β), COUP-TFI (chicken ovalbumin upstream promoter-transcription factor I) e Nur77 (nuclear receptor 77). Em comparação ao grupo OM, a expressão de RXRα e RARβ foi maior (p<0,05) especificamente em pLPN e rLPN do grupo βI, respectivamente. Em comparação ao grupo N, Nur77 apresentou maior (p<0,05) expressão no surrounding e nas rLPN do grupo OM. Por outro lado, a expressão de Nur77 em rLPN foi menor (p<0,05) no grupo BI do que no OM. Comparada ao grupo N, a expressão de COUP-TFI foi maior (p<0,05) no grupo OM, tanto no surrounding das LPN como nas pLPN e rLPN. Em comparação ao grupo OM, a expressão de COUP-TFI foi menor (p<0,05) no grupo BI, especificamente nas pLPN e nas rLPN. Os resultados sugerem que os receptores nucleares RXRα, RARβ, Nur77 e COUP-TFI representam alvos moleculares da BI relevantes para a quimioprevenção da hepatocarcinogênese em ratos. / β-ionone (BI) is an isoprenoid which has chemopreventive activity during the promotion phase of hepatocarcinogenesis. This study aimed to evaluate the expression of genes modulated by BI involved in chemoprevention during the promotion phase of hepatocarcinogenesis induced model of \"Resistant Hepatocyte (RH). Male Wistar rats were submitted to the RH model and treated for 4 consecutive weeks with BI (16 mg/100 g bw) or corn oil (CO) (0.25 ml/100 g bw, control group). The expression profile of 1,176 genes was analyzed by macroarray in the liver of groups BI, CO and normal rats (group N). Gene expression was considered increased when the expression ratio was 1.5 or decreased when 0.5. Hierarchical clustering analysis and ontological classification of differentially expressed genes were applied. Gene expression was validated by RT-PCR \"duplex\", using microdissected hepatic tissue from: persistent pre-neoplastic lesions (pPNL) or remodeling pre-neoplastic lesions (rPNL) and regions around the PNL (surrounding). A total of 133 genes and 32 were considered differentially expressed between the two groups (CO to N) and BI (relative to CO), respectively. 37% of differentially expressed genes in group BI vs CO were related to cell receptors. Of these, four genes encoding for nuclear receptors have been identified as possible targets of BI in the chemoprevention of hepatocarcinogenesis: RXR (retinoid X receptor α), RARβ (retinoic acid receptor β), COUP-TFI (chicken ovalbumin upstream promoter-transcription factor I) and Nur77 (nuclear receptor 77). Compared to CO group, the expression of RXRα and RARβ was higher (p <0.05) specifically in pPNL and rPNL of BI group, respectively. Compared to the group N, Nur77 showed higher (p <0.05) expression in the surrounding and rPNL of CO group. The expression of Nur77 in rPNL was lower (p <0.05) in BI than the CO group. Compared to N group, the expression of COUP-TFI was higher (p <0.05) in CO group (surrounding, pPNL and rPNL). Compared to CO group, the expression of COUP-TFI was lower (p <0.05) in BI group, specifically in the pPNL and rPNL. The results suggest that the nuclear receptors RXRα, RARβ, Nur77 and COUP-TFI represent relevant molecular targets of BI in the chemoprevention of hepatocarcinogenesis in rats.
|
9 |
Development of novel unsupervised and supervised informatics methods for drug discovery applicationsMohiddin, Syed B. 22 February 2006 (has links)
No description available.
|
10 |
Etude théorique des processus électroniques ayant lieu au cours de collisions atomiques et moléculaires : approches non perturbatives / Theoretical studies of electronic processes in atomic and molecular collisions : non perturbative approachesAgueny, Hicham 03 April 2014 (has links)
Deux domaines différents de la physique des collisions ont fait l’objet de mes travaux de thèse réalisés dans le cadre d'une cotutelle entre l'Université Moulay Ismail, Meknes-Maroc et l'Université Pierre et Marie Curie, Paris-France: le premier concerne les collisions ion-atome/molécule dans le régime des énergies intermédiaires (keV), alors que le second vise le domaine des collisions électron-atome assistées par un champ laser intense. Bien que distincts, les deux thèmes sont interconnectés puisqu'il s'agit principalement d'étudier, dans des approches non-perturbatives, les phénomènes de diffusion et la dynamique électronique des collisions de cibles atomiques et moléculaires soumis à de fortes et très courtes perturbations. La première partie porte spécifiquement sur la modélisation des processus de transfert électronique et d'ionisation induits lors de collisions d'ions et de cibles atomiques et moléculaires. L'étude porte particulièrement sur les phénomènes d'interférences de type Young, de multi-diffusion et de diffraction Fraunhofer observés au cours de ces processus. La deuxième partie de thèse repose sur une étude des processus de diffusion élastiques et inélastiques induits lors de collisions assistées par un champ laser intense. L'étude s’appuie sur l’analyse spécifique des transitions "libre-libre" au cours lesquelles la cible reste dans son état fondamental après la collision, et des phénomènes de résonance dans le processus d'excitation simultanée électron-photon de la cible. / This work has been performed as a joint PhD between Université Moulay Ismail, Meknes-Morocco, and Université Pierre et Marie Curie, Paris-France. It concerns two different areas of collision physics: the first part of my research covers the study of ion-atom/molecule collisions in the intermediate energies (keV) , while the second deals with laser-assisted electron-atom scattering. The two subjects are interconnected since both concern the description of electronic processes occurring in scattering events and the study of highly non linear response of atomic and molecular targets to high or short time-dependent perturbations. The first part of the thesis focuses specifically on the modeling of electron transfer and ionization processes induced in collisions of ions and atomic/molecular targets. My work concentrates mainly on the phenomena of Young-type interferences, multi-scattering and Fraunhofer diffraction observed during these processes. The second part concerns the study of elastic and inelastic processes induced in electron-atom collisions in the presence of a strong laser field. The investigations focus on free, free transitions, in which the target remains in its initial state after the collision, and resonance phenomena in more complex processes where the target is simultaneously excited by the the electron-projectile and the radiation and when collisional and radiative interactions are strong enough to concurrently modify the internal state of the target
|
Page generated in 0.0713 seconds